Clarivate Deals Report Highlights Emerging Trends in Biopharma Deal-Making
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology related deals dominate the landscape Biotech companies in U.S. awarded largest sums of capital, followed by Mainland China... | March 14, 2022